Cargando…
Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is undoubtedly the most challenging pandemic in the current century and remains a global health emergency. As the number of COVID-19 cases in the world is on the rise and variants continue to e...
Autores principales: | Liu, Cong, Rcheulishvili, Nino, Shen, Zhigao, Papukashvili, Dimitri, Xie, Fengfei, Wang, Ziqian, Wang, Xingyun, He, Yunjiao, Wang, Peng George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143166/ https://www.ncbi.nlm.nih.gov/pubmed/35631687 http://dx.doi.org/10.3390/pharmaceutics14051101 |
Ejemplares similares
-
Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022) -
Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
por: Papukashvili, Dimitri, et al.
Publicado: (2022) -
Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy
por: Papukashvili, Dimitri, et al.
Publicado: (2021) -
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
por: Liu, Cong, et al.
Publicado: (2022) -
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
por: Wang, Xingyun, et al.
Publicado: (2023)